Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.56 |
| ▸ | LMNA | P02545 | 5/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | THPO | P40225 | 3/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.37 |
| ▸ | BLM | P54132 | 2/20 | 0.37 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | GMNN | O75496 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL180144 | 0.97 | TSHR (0.53) | TSHRLMNACYP1A2TDP1KMT2A | |
| Hydrochloric Acid SCHEMBL1844352 | 0.97 | TSHR (0.53) | TSHRLMNACYP1A2TDP1KMT2A | |
| SCHEMBL5067235 | 0.91 | TSHR (0.48) | TSHRLMNACYP1A2TDP1KMT2A | |
| SCHEMBL163253 | 0.91 | TSHR (0.72) | TSHRLMNACYP1A2TDP1KMT2A | |
| SCHEMBL14235175 | 0.89 | TSHR (0.46) | TSHRLMNACYP1A2TDP1KMT2A | |
| SCHEMBL6548055 | 0.88 | TSHR (0.43) | TSHRLMNACYP1A2TDP1KMT2A | |
| SCHEMBL19308751 | 0.87 | — | — | |
| SCHEMBL16358111 | 0.85 | — | — | |
| SCHEMBL3078846 | 0.84 | TSHR (0.45) | TSHRLMNACYP1A2TDP1KMT2A | |
| SCHEMBL14042508 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 690 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122011511-A | Nanometer clay composite reinforcing agent for rubber and preparation method thereof | 宁波嘉和新材料科技有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-12576163-B2 | Fluorescent contrast agent with targeting function, and preparation method and use thereof | PEKING UNIVERSITY THIRD HOSPITAL (CN) | 2026-03-17 | — | — | US | claimed |
| EP-4689130-A2 | METHODS AND COMPOSITIONS FOR ENHANCED EXPRESSION OF EXOGENOUS CASEINS IN TRANSGENIC PLANTS | Mozza Foods Inc. (US) | 2026-02-11 | — | — | EP | claimed |
| US-20250369916-A1 | ELECTROCHEMICAL BIOSENSOR, PREPARATION METHOD, AND USE | SHANGHAI UNITED IMAGING MICROELECTRONICS TECH CO LTD (CN) | 2025-12-04 | — | — | US | claimed |
| EP-4656733-A1 | ELECTROCHEMICAL BIOSENSOR, PREPARATION METHOD, AND USE | Shanghai United Imaging Microelectronics Technology Co., Ltd. (CN) | 2025-12-03 | — | — | EP | claimed |
| CN-119101214-A | Cycloolefin metathesis composition and polymerization method thereof | 道生天合材料科技(上海)股份有限公司 | 2024-12-10 | — | — | CN | claimed |
| US-20240336895-A1 | METHODS FOR RAPIDLY INFILTRATING 3D SCAFFOLDS WITH CELLS | SPIDERWORT INC. (CA) | 2024-10-10 | — | — | US | claimed |
| WO-2024206469-A2 | METHODS AND COMPOSITIONS FOR ENHANCED EXPRESSION OF EXOGENOUS CASEINS IN TRANSGENIC PLANTS | Mozza Foods Inc. (US) | 2024-10-03 | — | — | WO | claimed |
| EP-3470418-B1 | SITE-SPECIFIC RADIOISOTOPE-LABELED ANTIBODY USING IGG-BINDING PEPTIDE | UNIV KAGOSHIMA (JP) | 2024-07-31 | — | — | EP | claimed |
| EP-4377442-A1 | METHODS FOR RAPIDLY INFILTRATING 3D SCAFFOLDS WITH CELLS | Spiderwort Inc. (CA) | 2024-06-05 | — | — | EP | claimed |
| US-20080125365-A1 | ISOLATED COMPLEXES OF COVALENTLY CROSS-LINKED ENDOTOXIN AND MODIFIED MD-2 | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2008-05-29 | — | — | US | claimed |
| US-20070254311-A1 | Covalent modification and conjugation of luciferase | CARDIOGENICS INC. (CA) | 2007-11-01 | — | — | US | claimed |
| WO-2007058678-A2 | USES OF PEGYLATED ALBUMIN | ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) | 2007-05-24 | — | — | WO | claimed |
| EP-1133318-B1 | SUPRAMOLECULAR COMPLEXES CONTAINING THERAPEUTIC AGENTS | CALIFORNIA INST OF TECHN (US) | 2007-03-14 | — | — | EP | claimed |
| WO-2006135740-A1 | PEGYLATED HEMOGLOBIN AND ALBUMIN AND USES THEREOF | ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) | 2006-12-21 | — | — | WO | claimed |
| EP-1175395-B1 | METHOD OF PREPARING N,N'-DISUBSTITUTED-3,3'-DITHIODIPROPIONAMIDE AND METHOD OF PREPARING SUBSTITUTED 3-ISOTHIAZOLONE BY USING THE SAME | SK CHEMICALS CO LTD (KR) | 2004-09-22 | — | — | EP | claimed |
| WO-1997043645-A1 | ANTIBODIES DIRECTED AGAINST DITHIOCARBAMATES | MEDINOX, INC. (US) | 1997-11-20 | — | — | WO | claimed |
| EP-0248621-B1 | REAGENT FOR IMMUNOASSAY | KABUSHIKI KAISHA TOSHIBA (JP) | 1992-08-26 | — | — | EP | claimed |
| EP-0157797-A1 | DETECTING AN IMMUNOLOGICAL REACTION WITH ACTIVATED RED BLOOD CELLS (ERYTHROCYTES) | IMMUCOR, INC. (US) | 1985-10-16 | — | — | EP | claimed |
| WO-1985001354-A1 | DETECTING AN IMMUNOLOGICAL REACTION WITH ACTIVATED RED BLOOD CELLS (ERYTHROCYTES) | IMMUCOR, INC. (US) | 1985-03-28 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12576163-B2 | Fluorescent contrast agent with targeting function, and preparation method and use thereof | CD209, FUT7, MUC1 | TSHR 880/4885LMNA 2535/4885CYP1A2 3401/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.